In:
Pulmonary Circulation, Wiley, Vol. 11, No. 4 ( 2021-10), p. 1-5
Abstract:
Whether mutations in the BMPR2 gene may influence the response to PAH‐specific therapies has not yet been investigated. In this study, in 13 idiopathic, heritable or anorexigen‐associated PAH patients, in whom treatment escalation was performed by adding a prostanoid, a greater haemodynamic improvement was observed in BMPR2‐negative than in BMPR2‐positive patients.
Type of Medium:
Online Resource
ISSN:
2045-8940
,
2045-8940
DOI:
10.1177/20458940211037275
Language:
English
Publisher:
Wiley
Publication Date:
2021
detail.hit.zdb_id:
2638089-4
Permalink